Released: November 06, 2026
Step 1 of 2
The diverse clinical presentations of systemic mastocytosis can complicate timely diagnosis, disease classification, and individualized treatment selection across indolent and advanced disease. This social media forum invites learners to submit questions and challenging cases for faculty guidance on applying diagnostic criteria, interpreting KIT mutation test results, assessing disease burden and risk, and selecting and sequencing therapies. The discussion will also address anaphylaxis prevention, safety monitoring, treatment response, and multidisciplinary care, helping learners apply symposium insights to patient-centered management decisions throughout the certified life of the program.